SCHEMBL1070872

SCHEMBL1070872

CNC(=Cc1ccccc1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.55
AKR1C1 Q04828 1/20 0.48
RECQL P46063 1/20 0.47
HTT P42858 2/20 0.46
ALDH1A1 P00352 2/20 0.45
TSHR P16473 1/20 0.45
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
TP53 P04637 1/20 0.42
MTNR1A P48039 2/20 0.42
MTNR1B P49286 2/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42
FBP1 P09467 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13879068 1.00 AKR1C3 (0.55) AKR1C3AKR1C1RECQLHTTALDH1A1
SCHEMBL21091997 0.86 ALDH1A1 (0.48) AKR1C3AKR1C1RECQLHTTALDH1A1
SCHEMBL14003231 0.86 RECQL (0.55) AKR1C3AKR1C1RECQLHTTALDH1A1
SCHEMBL14003229 0.86 RECQL (0.55) AKR1C3AKR1C1RECQLHTTALDH1A1
SCHEMBL20610671 0.84 MCL1 (0.49) AKR1C3AKR1C1RECQLHTTALDH1A1
SCHEMBL27542414 0.81 ALDH1A1 (0.42) AKR1C3AKR1C1RECQLHTTALDH1A1
SCHEMBL786716 0.80 AKR1C3 (0.57) AKR1C3AKR1C1RECQLHTTALDH1A1
SCHEMBL388143 0.80 AKR1C3 (0.57) AKR1C3AKR1C1RECQLHTTALDH1A1
SCHEMBL388142 0.80 AKR1C3 (0.57) AKR1C3AKR1C1RECQLHTTALDH1A1
SCHEMBL8993857 0.79 AKR1C3 (0.50) AKR1C3AKR1C1RECQLHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268285-A1 THERAPEUTIC COMPOUNDS Merck Sharp & Dohme Corp. (US) 2011-01-05 EP disclosed
WO-2009108507-A1 THERAPEUTIC COMPOUNDS MERCK & CO., INC. (US) 2009-09-03 WO disclosed